Delivery Order SPE2DB22D3301-SPE2DB25FZ1KF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loryna 3 mg-0.02 mg tablets in quantities of 28 with a ceiling value of $9,337.76. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) valued at $1,875.80. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order will be fulfilled from the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,286.11 to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 26, 2025, with an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) with a ceiling value of $1,366.30. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will take place at the contractor's facility in Conshohocken, Pennsylvania. The order is expected to be completed by August 18, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Loryna 3 mg-0.02 mg tablets (28-count) with a ceiling value of $1,004.30. This competitively awarded, firm fixed-price contract, issued on September 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) with a ceiling value of $5,258.67. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,963.54 to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packages) with a completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packages) under a firm fixed-price contract with a ceiling value of $5,381.36. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,951.88 Firm Fixed Price Delivery Order contract is for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of January 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product "LORYNA 3 MG-0.02 MG TABLET 28S." The contract award, valued at $1,298.40, has an ultimate completion date of April 1, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1KFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28 count) with a firm fixed price ceiling value of $1,049.59. This is a competitive award with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that extends through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of pharmaceutical and medical supply deliveries. The company's federal contract awards demonstrate capability across multiple therapeutic domains, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for Loryna tablets exemplifies the company's role in supporting Department of Defense medical procurement needs through the DLA's comprehensive pharmaceutical supply chain, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/23/25 |